Engineers Gate Manager’s iTeos Therapeutics ITOS Stock Holding History

Engineers Gate Manager’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-59,559	Closed	-$594K	–	2347
2025 Q2	$594K	Buy	59,559 +22,749	+62%	+$183K	0.01%	1402
2025 Q1	$220K	Buy	+36,810	New	+$270K	﹤0.01%	1852
2024 Q1	–	Sell	-11,880	Closed	-$130K	–	2099
2023 Q4	$130K	Buy	+11,880	New	+$118K	﹤0.01%	1732

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Engineers Gate Manager's ITOS Position: Q3 2025 in Review

Engineers Gate Manager sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 59,559 shares — an estimated $594K sold.

Engineers Gate Manager first reported a position in ITOS in Q4 2023 and held it in 3 quarters. The position peaked at $594K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Engineers Gate Manager reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Engineers Gate Manager sold 59,559 iTeos Therapeutics shares in Q3 2025, an estimated $594K.
Engineers Gate Manager first reported a position in iTeos Therapeutics in Q4 2023 and held it in 3 quarters.
Engineers Gate Manager's iTeos Therapeutics position peaked at $594K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Engineers Gate Manager's 13F filing for Q3 2025, filed 14 Nov 2025.